key: cord-0877843-11i5bted
authors: Alawna, Motaz; Mohamed, Ayman A.
title: An integrated intervention combining cognitive‐behavioural stress management and progressive muscle relaxation improves immune biomarkers and reduces COVID‐19 severity and progression in patients with COVID‐19: A randomized control trial
date: 2022-04-20
journal: Stress Health
DOI: 10.1002/smi.3151
sha: af5440bad94a0f67d189ebe78b2220266c0357d3
doc_id: 877843
cord_uid: 11i5bted

COVID‐19 is a world disaster. In response to COVID‐19 quarantine, stress, anxiety, and depression may easily develop which negatively affect immunity and decrease the patient's response against the COVID‐19 virus. This study investigated the effect of an integrated intervention combining cognitive‐behavioural stress management (CBSM) and progressive muscle relaxation (PMRs) on immune biomarkers and disease severity and progression in patients with COVID‐19 and the period to which these changes last. Thirty patients with mild or moderate COVID‐19 were randomly distributed into intervention and control groups. The intervention group performed an integrated intervention combining CBSM and PMRs. There were three outcome measures including blood immune markers, salivary immunoglobulin A, and Wisconsin scale (WIS). Two‐week post‐intervention, there were significant differences between groups in the WIS total score, Leucocytes, Lymphocytes, Interleukin‐6, and Immunoglobulin‐A. While there were non‐significant differences between both groups in Interleukin‐10 and TNF‐α. The significant differences between groups in the WIS total score, Leucocytes, Lymphocytes, Interleukin‐6, and Immunoglobulin‐A significantly continued 1 week as a follow‐up. This study concluded that performing an integrated intervention combining CBSM and PMRs for 2 weeks significantly increases immune biomarkers mainly Leucocytes, Lymphocytes, Interleukin‐10, and Interleukin‐6 along with S‐IgA. Also, this protocol significantly decreases disease severity and associated stress, anxiety, and depression; and enhances the quality of life in patients with COVID‐19. The study was retrospectively registered with NCT04998708.

COVID-19 is a world disaster. According to the World Health Organization, COVID-19 has infected more than 200,840,180 cases, including 4,265,903 deaths on 5 August 2021 Outbreak, 2020) . is known as an enclosed RNA beta-coronavirus-type (Gorbalenya et al., 2020) . The most followed protocol in the management of COVID-19 is a quarantine for 14 days. In response to this quarantine, stress, anxiety, and depression may easily develop in patients with COVID-19 (Rajkumar, 2020) . Symptoms of anxiety and depression commonly develop as a response to COVID-19 quarantine (Rajkumar, 2020) . A recent meta-analysis demonstrated that stress, anxiety, and depression transiently develop as a response to quarantine. The prevalence of transit stress, anxiety, and depression are 29.6%, 31.9%, and 33.7% respectively (Salari et al., 2020) .

Stress suppresses the activity of the hypothalamic-pituitaryadrenal (HPA) axis identified as the chief stress regulator in humans. Consequently, a decrease in the normal control of the neuro-endocrine system occurs. The hypothalamus releases corticotropin-releasing factors (CRFs; Mohamed & Alawna, 2020b; Zamani-Alavijeh et al., 2018) . These CRFs bind to specific receptors on the anterior pituitary gland to trigger the release of adrenocorticotropic hormone (ACTH). Adrenocorticotropic hormone releases cortisol hormone via binding to specific receptors on the adrenal cortex. In stressful conditions, serum cortisol increases leading to suppression of immune function along with the release of key body inflammation substances (prostaglandins and leukotrienes). This reduces the activity and function of immune cells (eosinophil, basophil, macrophages, neutrophil, mast cells T-lymphocytes, and B-lymphocytes; Geraghty & Kaufer, 2015; Goppelt-Struebe et al., 1989; Mohamed & Alawna, 2020b) . Thus, a decrease in the body's defense to COVID-19 infections and an increase in COVID-19 progression and severity occur Mohamed & Alawna, 2020b) .

The body acts to resolve stress, anxiety, and depression by promoting complex and interconnected cellular, neuroendocrine, and molecular infrastructures. This occurs via several adaptations in both peripheral and central nervous systems (Mohamed & Alawna, 2020b; Tsigos et al., 2000) . Thus, immune strength is crucial in the management of COVID-19 infections. Consequently, therapies that improve immune function are important to be performed during the quarantine period (Mohamed & Alawna, 2021b; Mohamed & Alawna, 2020a; Mohamed et al., 2020) . Previously, we investigated the effect of aerobic exercise as a therapy to improve immune function (Mohamed & Alawna, 2021a) . We found that aerobic exercise significantly increased immune function. In addition, it significantly decreased COVID-19 disease progression and severity.

Different studies were conducted earlier to demonstrate the important role of relaxation techniques for patients with COVID-19 (Ozamiz-Etxebarria et al., 2020; Özlü et al., 2021; Xiao et al., 2020) .

They mainly investigate the effect of relaxation techniques on anxiety, sleep quality, and negative emotions. All these studies did not investigate the effect of these relaxation techniques on neither immune function nor COVID-19 progression and severity which are crucial and specified to COVID-19. Progressive muscle relaxation (PMRs) techniques were commonly used in COVID-19 related studies. These techniques have a high controversy on their effect on immune function. Ikemata and Momose investigated the effects of PMRs on activities of daily living, dementia symptoms, and immune function in group home residents with dementia in Japan (Ikemata & Momose, 2017) . They found that PMRs enhance behavioural and psychological symptoms of dementia and activities of daily living in group home residents with dementia but does not affect their immune function. In contrast, Pawlow and Jones investigated the effects of brief PMRs on salivary cortisol and salivary immunoglobulin A (Pawlow & Jones, 2005) . They found that brief PMRs significantly reduce salivary cortisol and increase salivary immunoglobulin A concentration and secretion rate. A recent systematic and metaanalysis review supported the effectiveness of stress-reducing interventions in enhancing immunity in studies that tested immune function by methods of incorporating an in vitro, in vivo, or psychophysiological challenge (Schakel et al., 2019) . (Antoni et al., 1991) . They found that CBSM significantly increased helper-inducer (CD4) and natural killer (CD56) cell counts in addition to a slight increase in proliferative responses to phytohaemagglutinin.

Improving immune function is a key in the management of COVID-19. Interventions that improve the psychological status of patients may be helpful in counter fight COVID-19. Thus, we conducted this study to investigate the effect of an integrated intervention combining CBSM and PMRs on immune biomarkers and disease severity and progression in patients with COVID-19 and the period to which these changes last.

A randomized controlled design was used. The study was double blinded in which both patients and assessors were blinded to study procedures. Each patient was asked to sign an informed consent before participation in this study. This study was approved by the ethics committee of the School of Health Sciences, Istanbul Gelisim University, Turkey. Patients were recruited from December 2020 to April 2021. The patients were collected by reviewing the hospital's 2 -ALAWNA AND MOHAMED data in Istanbul, Turkey. Then, we called patients with COVID-19 to ask them about their welling to participate in this study. Patients who accepted to participate were interviewed through video calls using Zoom App to discuss study procedures with them. Patients who accepted to engage in this study were visited by a researcher at their home while they are in quarantine. Through the initial visit, the consent form was signed, and blood samples were taken. Any patient must have permission to perform our intervention from the physician who supervises him/her. The clinical protocol of this study was retrospectively registered at the https://www.clinicaltrials.govplatform with a registration number of NCT04998708. The study was registered retrospectively for several reasons including the vulnerability of the whole research team to have COVID-19, participants being hospitalized, lab closure, city lockdown…. etc. which significantly can affect the dates and data of the trial. There were no deviations from the registered trial protocol.

The suitable sample size for this study was determined using a priori power test. The G*POWER programme (ver. 3.1.9.2, Heinrich-Heine-University) was used. The criteria entered into the programme included a multivariate analysis of repeated measurements (MAN-OVA) test using 2 groups, 2 measurements, a power level of 80%, a significance level of 0.05, and a medium effect size (dz = 0.25 ; Faul et al., 2007) . Based on the previous assumptions, the total sample size needed for this study was 30 patients. A minimum power of 80% or more is acceptable in most studies (Kadam & Bhalerao, 2010) . The flow of patients throughout the study is shown in Figure 1 .

Initially, 45 patients accepted the participation in this study. Ten patients did not meet the study inclusion criteria and additional five patients did not complete the whole study because they did not like doing exercise. Finally, 30 patients with COVID-19 completed the whole study (2 weeks intervention and 3 weeks post-intervention 'follow-up'). The study ended after the completion of the intervention.

The patients' age ranged from 25 to 45 years old. The inclusion criterion included that the patient had a recent mild or moderate COVID-19 with no or low-grade fever 99.5-100.94°F (37.5-38.3°C; Affronti et al., 2010; Zhuang et al., 2020 (Yuki et al., 2020) . The exclusion criteria included that the patient was indicated for hospitalization, the patient has high-grade fever >100.94°F (>38.3°C), or the patient had other chronic diseases such as heart problems, hypertension, or diabetes. Women on contraceptives were excluded because contraceptives decrease immune function increase the risk of various autoimmune disorders (Williams, 2017) .

There were three main dependent variables including blood immune markers, salivary immunoglobulin A, and Wisconsin Upper Respiratory Symptom Survey. These measurements were collected at the baseline, 2 weeks post-intervention, and 1 week as a follow-up.

A lab technician and one researcher were asked to visit the pa- 

Blood samples were taken in the morning (8:30-9:30) by collecting 10 ml of venous blood. Patients were asked to stop any exercise for at least 24 h before blood sampling. Also, patients were asked to stop eating or drinking 8 h before collecting samples. Samples were collected in vacutainer tubes with sodium ethylenediami-netetraacetic acid (EDTA) for plasma separation. The blood was centrifuged at 3000 rpm for 15 min at 4°C. The total lymphocytes, leucocytes, and monocytes were measured utilizing a multichannel haemocyte analysis system (SE-9000; Sysmex Corp.; Lira et al., 2017; Shimizu et al., 2011) .

The concentrations of IL-6, IL-10, and TNF-α were analyzed by using ELISA commercial kits assay (R&D Systems). The manufacturer's instructions for analysis of IL-6, IL-10, and TNF-α on an EZ-Reader microplate reader at 450 nm were followed (de Souza et al., 2018; Lira et al., 2017) . The samples were stored at −20°C for further analysis.

The saliva sample was taken without any saliva stimulation methods.

The patient was asked to rinse their mouths with distilled water and evacuate their mouth just before the collection. We used the passive drainage method for this collection. The patient slightly flexed their head forward to allow the saliva to move into a sterilized and preweighed Falcon tube for 5 min. The weight of tubes was measured again following the collection to estimate the volume and the saliva flow rate. The tubes were weighed with 0.1 mg accuracy with the proposed saliva density proposed at 1.0 g ml −1 . The samples were stored at −80°C for further analysis. The S-IgA concentration was analyzed utilizing commercial ELISA kits (IgA Salivary, DRG). The IgA-S secretion rate (ng/min) was measured by multiplying the whole concentration of IgA-S present in the mucosal surface per unit of time by the saliva flow rate (ml/min; de Souza et al., 2018).

The Wisconsin Upper Respiratory Symptom Survey is an empirically derived patient-oriented illness-specific quality-of-life evaluative outcomes instrument (Barrett & Barrington, 2005) . The development process of this survey was described in detail by Barrett et al. (2018) . Barrett et al., 2018) . The patients were asked to fill the survey at the baseline, 2 weeks post-intervention, and 1 week as a follow-up.

Patients were assigned randomly into intervention, and control groups. Patients were randomly allocated to four permuted blocks using computer software to have two equal sample sizes. The randomization was performed by a college staff member who was not involved in this study. All patients in the groups followed the WHO procedures of quarantine (WHO, 2020a) and took standardized medications administered by the Turkish Ministry of Health (Hydroxychloroquine Sulphate 200 Mg).

The intervention group performed an integrated intervention combining CBSM and PMRs. We used these two interventions because it has been shown their positive effects on immune function.

The two relaxation techniques included PMR training (Xiao et al., 2020) and CBSM (McGregor et al., 2004) . We used two types of relaxation techniques to produce maximum effects of relaxation techniques within the limited period of COVID-19 quarantine (2 weeks). The control groups did not receive any relaxation techniques during the study.

Progressive muscle relaxation training has been reported to decrease anxiety, negative emotions, and enhance sleep quality in patients with 4 -ALAWNA AND MOHAMED COVID-19 (Özlü et al., 2021; Xiao et al., 2020) . The patients performed PMR in their bed for 30 min in the morning after waking up and at night before sleeping. We recorded a detailed video for PMR to be watched by all patients before participating in this study. The PMR order was initiated by doing isometric contractions of muscles with a concentration on the sensation of tension for 3-5 s. Then, they take a rest for 10-15 s. Next, the patients were instructed to perform the PMR in this sequence foot, leg, hip and waist, chest, arm, shoulder, and face. The specific instructions for each exercise were demonstrated in the study of Özlem et al. (2021) . The patient should at least complete 12 days of PMRs to be included in the statistical analysis.

Cognitive-behavioural stress management has been reported to significantly decrease depression, anxiety, and stress in patients with COVID-19 (Li et al., 2020) . All included patients were taken a 2-h structured group session to illustrate the CBSM in detail before starting the study. All sessions were conducted by a hired psychologist who was blinded to study procedures. The CBSM consisted of a 2-h structured group session performed two times/week. Each session focussed on various CBSM techniques (e.g., coping skills training, cognitive restructuring, assertion training, and stress management).

The patients also were asked to do homework assignments (e.g., relaxation monitoring cards and a cognitive restructuring worksheet)

given each week. The patient should attend all 2-h structured group sessions and do all assignments to be included in the statistical analysis.

Patients' files were encoded by a university administrator who did not join this study (Taylor & Murphy, 2010) . Intention-to-treat and general linear models of analysis were followed. A MANOVA test was used to measure within each group interactions, while an independent MANOVA test was used to measure between-groups comparisons. The outcome measures were measured at the baseline, 2 weeks post-intervention, and 1 week as a follow-up. All results were compared to the baseline results. The baseline characteristics of patients in both groups were compared using Pearson chi-squared tests for categorical variables (gender, previous lung infection history) and t-test for continuous variables (age and body mass index).

The significance level was set at p < 0.05. The SPSS (ver. 25, IBM Inc.) was used for statistical analysis.

At the baseline, there were non-significant differences between groups in age, and body mass index (p > 0.05). All measurements were normally distributed in both groups (Shapiro-Wilk test, p > 0.05; Rochon et al., 2012) . The demographic and physical features of all patients at the baseline are demonstrated in Table 1 . All included patients in the intervention group performed PMRs for at least 12 days. Also, all included patients attended all 2-h structured group sessions and do all assignments.

At baseline measurements, there were non-significant differences between both groups in the Wisconsin scale (WIS) total score, Lymphocytes, Leucocytes, Interleukin-6, Interleukin-10, TNF-α, and Immunoglobulin-A (p > 0.05). Two weeks post-intervention, there were significant differences between groups in the WIS total score, Leucocytes, Lymphocytes, Interleukin-6, and Immunoglobulin-A (p < 0.05). While there were non-significant differences between both groups in Interleukin-10 and TNF-α. The significant differences between groups in the WIS total score, Leucocytes, Lymphocytes, Interleukin-6, and Immunoglobulin-A continued 1 week as a followup (p > 0.05). Between-groups comparisons are shown in Table 2 and Figure 2.

The WIS total score significantly reduced in control and intervention groups 2 weeks post-intervention (p < 0.05). This significant decrease continued for 1 week as a follow-up. Leucocytes, Lymphocytes, and Interleukin-10 significantly increased in control and intervention groups 2 weeks post-intervention (p < 0.05). These significant increases continued for 1 week as a follow-up. Immunoglobulin-A and Interleukin-6 significantly increased in the intervention group (p < 0.05) only, while they non-significantly increased in the control group 2 weeks post-intervention (p > 0.05). These results continued the same 1 week as a follow-up. TNF-α non-significantly increased in both groups 2 weeks post-intervention (p < 0.05). This nonsignificant increase continued for 1 week as a follow-up. Withingroup comparisons are demonstrated in Table 3 and Figures 3 and 4 . Hines et al., 1996; Rodríguez et al., 2005) . F I G U R E 2 Independent measure multivariate analysis of repeated measurements (MANOVA) between groups at the baseline after 2 weeks of the intervention, and 1 week after the study (follow-up). At baseline measurements, there were non-significant differences between both groups in the Wisconsin scale (WIS) total score, Lymphocytes, Leucocytes, Interleukin-6, Interleukin-10, TNF-α, and Immunoglobulin-A (p > 0.05). After 2 weeks of intervention, there were significant differences between both groups in the WIS total score, Leucocytes, Lymphocytes, Interleukin-6, and Immunoglobulin-A (p < 0.05). While there were non-significant differences between both groups in Interleukin-10 and TNF-α. One-week post-intervention of the study, the significant differences between both groups in the WIS total score, Leucocytes, Lymphocytes, Interleukin-6, and Immunoglobulin-A which occurred after the study continued significant (p > 0.05). Abbreviations: IgA, Immunoglobulin-A; Int-10, Interleukin-10; Int-6, Interleukin-6; Leuco (Griffith, 2020) . Future research should investigate the longterm effect of relaxation protocol on COVID-19 associated disorders and death rates.

T A B L E 3 Repeated measure multivariate analysis of repeated measurements (MANOVA) of immune biomarkers and Wisconsin scale (WIS) between the baseline, and 2 weeks after the intervention, and 1 week as a follow-up Baseline Two-weeks Follow-up F I G U R E 3 Repeated measure multivariate analysis of repeated measurements (MANOVA) for the Wisconsin scale (WIS) in both groups at the baseline, after 2 weeks of the intervention, and 1 week after the study (Follow-up). There was significant difference in the WIS in both groups and this significant difference continued till 1-week follow-up. Abbreviation: *, significance

Low-grade fever: How to distinguish organic from non-organic forms

Effects of increasing aerobic capacity on improving psychological problems seen in patients with COVID-19: A review

Cognitive-behavioral stress management intervention buffers distress responses and immunologic changes following notification of HIV-1 seropositivity

Bias in newspaper photograph selection

Meditation or exercise for preventing acute respiratory infection (MEPARI-2): A randomized controlled trial

Effects of highintensity interval and moderate

Immunoglobulin-A, and TNF at the baseline, after 2 weeks of the intervention, and 1 week after the study (Follow-up). Leucocytes, Lymphocytes, and Interleukin-10 significantly increased in control and intervention groups after the intervention (p < 0.05), and they continued significantly increased for 1-week follow-up. After 2 weeks of the intervention, Immunoglobulin-A and Interleukin-6 significantly increased in the intervention group (p < 0.05) only, while they non-significantly increased in the control group (p > 0.05); these results continued the same for 1-week follow-up. TNF-α non-significantly increased in both groups

G*Power 3: A flexible statistical power analysis program for the social, behavioral, and biomedical sciences

Active mind-body movement therapies as an adjunct to or in comparison with pulmonary rehabilitation for people with chronic obstructive pulmonary disease

Effects of glucocorticoids in the immune system

Glucocorticoids inhibit prostaglandin synthesis not only at the level of phospholipase A2 but also at the level of cyclo-oxygenase/PGE isomerase

Daily relaxation modifies serum and salivary immunoglobulins and psychophysiologic symptom severity

Men and COVID-19: A biopsychosocial approach to understanding sex differences in mortality and recommendations for practice and policy interventions

Selective IgA deficiency (SIgAD) and common variable immunodeficiency (CVID)

Exercise and immunity: A review with emphasis on the horse

Effects of a progressive muscle relaxation intervention on dementia symptoms, activities of daily living, and immune function in group home residents with dementia in Japan

Levels of immune cells in transcendental meditation practitioners

Effects of mind-body training on cytokines and their interactions with catecholamines

The effect of relaxation interventions on cortisol levels in HIV-sero-positive women

Sample size calculation

Dose effects of relaxation practice on immune responses in women newly diagnosed with breast cancer

The effect of cognitive behavioral therapy on depression, anxiety, and stress in patients with COVID-19: A randomized controlled trial

Short-term high-and moderate-intensity training modifies inflammatory and metabolic factors in response to acute exercise

The effect of diaphragmatic breathing on attention, negative affect and stress in healthy adults

Cognitive-behavioral stress management increases benefit finding and immune function among women with early-stage breast cancer

The effect of aerobic exercise on immune biomarkers and symptoms severity and progression in patients with COVID-19: A randomized control trial

Enhancing oxygenation of patients with coronavirus disease 2019: Effects on immunity and other health-related conditions

Role of increasing the aerobic capacity on improving the function of immune and respiratory systems in patients with coronavirus (COVID-19): A review

Aerobic exercises recommendations and specifications for patients with COVID-19: A systematic review

Important role of relaxation techniques on immune functions, glycemic control, and stress in diabetic patients with COVID-19: A review

Reduction of COVID-19 anxiety levels through relaxation techniques: A study carried out in Northern Spain on a sample of young university students

The effects of progressive muscle relaxation exercises on the anxiety and sleep quality of patients with COVID-19: A randomized controlled study

The impact of abbreviated progressive muscle relaxation on salivary cortisol and salivary Immunoglobulin A (sIgA)

Increases in salivary lysozyme and IgA concentrations and secretory rates independent of salivary flow rates following viewing of a humorous videotape

COVID-19 and mental health: A review of the existing literature

To test or not to test: Preliminary assessment of normality when comparing two independent samples

Role of IgA in the defense against respiratory infections: IgA deficient mice exhibited increased susceptibility to intranasal infection with Mycobacterium bovis BCG

Prevalence of stress, anxiety, depression among the general population during the COVID-19 pandemic: A systematic review and metaanalysis

Effectiveness of stress-reducing interventions on the response to challenges to the immune system: A meta-analytic review

Monocyte and T-CELL responses to exercise training in elderly subjects

The immediate effects of 10-minute relaxation training on salivary immunoglobulin A (s-IgA) and mood state for Japanese female medical co-workers

Altered central integration of dual somatosensory input after cervical spine manipulation

Stress, endocrine physiology and pathophysiology

Effects of relaxation on psychobiological wellbeing during pregnancy: A randomized controlled trial

Impact of integrated amrita meditation technique on adrenaline and cortisol levels in healthy volunteers

Rational use of personal protective equipment for coronavirus disease 2019 (COVID-19) and considerations during severe shortages

Hormonal contraception and the development of autoimmunity: A review of the literature

Corona-virus disease (COVID-19) outbreak

Rational use of personal protective equipment for coronavirus disease

Effects of progressive muscle relaxation training on negative emotions and sleep quality in COVID-19 patients: A clinical observational study

The effectiveness of stress management training on blood glucose control in patients with type 2 diabetes

Low-grade fever during COVID-19 convalescence: A report of 3 cases

An integrated intervention combining cognitive-behavioural stress management and progressive muscle relaxation improves immune biomarkers and reduces COVID-19 severity and progression in patients with COVID-19: A randomized control trial